Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Enterome Bioscience
Enterome Bioscience
Activities:
Research & Development
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Recruitment
Enterome appoints Christophe Bonny as Chief Scientific Officer
Enterome is pioneering the development of novel pharmaceuticals and diagnostics to support personalised therapies in microbiome-related diseases
Research & Development
Takeda and Enterome announce drug discovery collaboration
To focus on microbiome targets across multiple gastrointestinal disorders
Research & Development
Enterome collaborates with J&J Innovation to develop novel targets and therapeutics for Crohn’s disease
French firm will receive an upfront payment plus R&D funding from Janssen
Research & Development
Enterome and Gustave Roussy collaborate to develop novel immunotherapy solutions to treat cancer
Alliance will extend the range of personalised treatment options for oncology patients
Research & Development
Enterome enters microbiome-based development collaboration with AbbVie in Crohn's disease
Tie-up aims to generate diagnostic products to support personalised therapies for microbiome-related diseases
Research & Development
Synthetic Biologics and Enterome Bioscience collaborate on microbiome research
Aim to assess the impact of beta-lactam anitbiotics on intestinal bacteria
Research & Development
Enterome appoints Alessandra Cervino as Head of Discovery
Brings genetic and genomic biomarkers experience to the company
Subscribe now